^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ABBV-383 IV

    i
    Other names: ABBV-383 IV, TNB-383B, TNB 383B
    Associations
    News
    Trials
    Company:
    AbbVie
    Drug class:
    CD3 agonist, BCMA inhibitor
    Related drugs:
    Associations
    News
    Trials